Meta Biomed Co., Ltd. (KOSDAQ:059210)
5,040.00
0.00 (0.00%)
At close: Feb 19, 2026
Meta Biomed Revenue
Meta Biomed had revenue of 23.53B KRW in the quarter ending September 30, 2025, with 1.66% growth. This brings the company's revenue in the last twelve months to 99.77B, up 8.09% year-over-year. In the year 2024, Meta Biomed had annual revenue of 94.04B with 13.16% growth.
Revenue (ttm)
99.77B
Revenue Growth
+8.09%
P/S Ratio
1.35
Revenue / Employee
327.10M
Employees
305
Market Cap
134.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 94.04B | 10.94B | 13.16% |
| Dec 31, 2023 | 83.10B | 14.16B | 20.54% |
| Dec 31, 2022 | 68.94B | 10.16B | 17.29% |
| Dec 31, 2021 | 58.78B | 13.78B | 30.63% |
| Dec 31, 2020 | 45.00B | -14.39B | -24.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maeil Holdings | 2.20T |
| Kortek | 363.35B |
| NH Nongwoobio | 151.03B |
| HYUNDAI BIOLAND | 129.68B |
| Com2uS Holdings | 91.57B |
| Samik Pharmaceutical Company LTD. | 58.88B |
| SEC Co.,Ltd. | 56.35B |
| Xperix | 19.78B |